HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery

INTRODUCTION: Adolescent girls and young women (AGYW) in Africa have high HIV incidence despite scale‐up of HIV testing and HIV treatment. Placebo‐controlled trials of tenofovir‐based pre‐exposure prophylaxi (PrEP) in diverse populations demonstrated that PrEP works with close to 100% effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Celum, Connie L, Delany‐Moretlwe, Sinead, Baeten, Jared M, van der Straten, Ariane, Hosek, Sybil, Bukusi, Elizabeth A, McConnell, Margaret, Barnabas, Ruanne V, Bekker, Linda‐Gail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643076/
https://www.ncbi.nlm.nih.gov/pubmed/31328444
http://dx.doi.org/10.1002/jia2.25298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643076/
https://www.ncbi.nlm.nih.gov/pubmed/31328444
http://dx.doi.org/10.1002/jia2.25298

Ejemplares similares